Sohini Das, Vinay Umarji And Virendra Singh Rawat

Stories by Sohini Das, Vinay Umarji And Virendra Singh Rawat

'We have to ensure vaccines work against new variants'

'We have to ensure vaccines work against new variants'

Rediff.com   11 Jan 2022

Adar Poonawalla says it took a five-minute chat with his father Cyrus before making the decision to manufacture Covishield. The bet paid off, and handsomely. Serum Institute now has the capacity to make 4 billion doses of Covishield annually.

Rotomac owner Vikram Kothari dies in freak accident

Rotomac owner Vikram Kothari dies in freak accident

Rediff.com   5 Jan 2022

Multi-core loan default accused and promoter of Rotomac Group 73-year-old Vikram Kothari died in a freak accident at his Kanpur residence on Tuesday morning. According to reports, the erstwhile stationery czar sustained grievous head injuries after slipping in his bathroom and later succumbed to his injuries. He was reportedly alone at his Tilak Nagar residence at the time of the incident. Vikram, also known as 'India's Pen King', was accused in a bank loan scam worth thousands of crores pertaining to Rotomac Global, which exported writing instruments overseas.

Covaxin shelf life extended, Bharat Biotech relabels old stocks

Covaxin shelf life extended, Bharat Biotech relabels old stocks

Rediff.com   5 Jan 2022

The company had in December said that the CDSCO had approved a 12-month shelf life for Covaxin, which was nine months earlier, Sohini Das reports.

Does India have enough jabs to expand vaccination drive?

Does India have enough jabs to expand vaccination drive?

Rediff.com   3 Jan 2022

A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield doses.

Covishield accounts for 88% of Covid jabs in India

Covishield accounts for 88% of Covid jabs in India

Rediff.com   1 Jan 2022

Serum Institute has the capacity to make 250 million doses of Covishield monthly.

Covaxin safe for children: Bharat Biotech

Covaxin safe for children: Bharat Biotech

Rediff.com   31 Dec 2021

Bharat Biotech is targeting to manufacture one billion doses of its intra-nasal vaccine in 2022 which is under clinical trials now.

'Antibodies induced by Covishield and Covaxin gradually increase and decrease'

'Antibodies induced by Covishield and Covaxin gradually increase and decrease'

Rediff.com   28 Dec 2021

'Antibodies remain in the blood for at least seven to nine months.'

Are You Eligible For A Booster Shot?

Are You Eligible For A Booster Shot?

Rediff.com   27 Dec 2021

'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.'

Covishield booster works against Omicron

Covishield booster works against Omicron

Rediff.com   24 Dec 2021

If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.

Gujarat Govt Remains Election-Focused

Gujarat Govt Remains Election-Focused

Rediff.com   23 Dec 2021

'The new cabinet intends to create an impression in people's minds that even if it is new, it is performing from day one.'

Rs 1.68 crore! The highest CTC at IIT-B this year

Rs 1.68 crore! The highest CTC at IIT-B this year

Rediff.com   22 Dec 2021

The highest domestic CTC is up by 163 per cent at IIT-Bombay's first phase of placements.

India's vaccine makers prepare to take on Omicron

India's vaccine makers prepare to take on Omicron

Rediff.com   8 Dec 2021

As the Omicron variant of Sars-CoV-2 takes centrestage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible.

Health expenditure's share in GDP down

Health expenditure's share in GDP down

Rediff.com   7 Dec 2021

The share of total health expenditure as part of the gross domestic product (GDP) went down to 3.3 per cent in 2017-18 from 3.8 per cent in the previous two years, according to the national health account data released on Monday by the health ministry. The share of government expenditure as part of total expenditure as well as GDP has gone up from from 3.78 per cent to 5.12 per cent between 2013-14 and 2017-18, which could also explain a decline seen in out of pocket expenditure in 2017-18. Health ministry also emphasised the increase in the government health expenditure as part of the total GDP from 1.15 per cent in 2013-14 to 1.35 per cent in 2017-18.

Nearly 33% of India's medical devices capacity lying unused

Nearly 33% of India's medical devices capacity lying unused

Rediff.com   7 Dec 2021

After ramping up production to meet the steep demand spike during the Covid-19 pandemic, Indian medical device makers are now struggling with idle capacity. According to industry estimates, around a third of the installed capacity, especially for consumables, disposables, small-ticket electronic items, etc., is lying unutilised. Sample this: India used to produce just 6.24 million pieces of PPE kits per annum before the pandemic, but by June this was ramped up to 233.87 million pieces per annum.

Omicron: 'Vaccine immunity may be less effective'

Omicron: 'Vaccine immunity may be less effective'

Rediff.com   7 Dec 2021

'Antiviral treatment will have no change. Spike protein change may affect the immunity protection.'

10 mn unused Covid vaccine doses lying with private hospitals

10 mn unused Covid vaccine doses lying with private hospitals

Rediff.com   1 Dec 2021

With around 2 million Covid vaccine doses likely to get wasted in December, leading hospital chains have now started to give it gratis to citizens. Sohini Das and Ruchika Chitravanshi report.

The highest placement offer at IIT-Guwahati is...

The highest placement offer at IIT-Guwahati is...

Rediff.com   29 Nov 2021

The institute has bagged 179 pre-placement offers so far, with the highest domestic offer at Rs 64 lakh per annum.

Nasal vaccine booster dose may be used with Covaxin

Nasal vaccine booster dose may be used with Covaxin

Rediff.com   27 Nov 2021

A nasal vaccine, one expert said, is a "fantastic idea" for two reasons -- one, it can potentially create sterile immunity, and two, it is easy to administer and thus scalable.

UP polls: Akhilesh Yadav ropes in small parties to make a comeback

UP polls: Akhilesh Yadav ropes in small parties to make a comeback

Rediff.com   23 Nov 2021

While Yadav began to tour different constituencies and address public meetings to mobilise the SP rank and file, he has concurrently started the tedious process of cobbling up an alliance of smaller outfits representing a mlange of castes and sub-castes, reports Virendra Singh Rawat.

Smaller parties maybe a force to reckon with in UP polls

Smaller parties maybe a force to reckon with in UP polls

Rediff.com   27 Oct 2021

In the backdrop of the ongoing farm protests, back into public consciousness in the aftermath of the recent Lakhimpur Kheri episode, smaller parties are expected to not only enliven the election theatre, but also queer the pitch for the Opposition.